Published in
Lippincott, Williams & Wilkins, HemaSphere, 6(6), p. e729, 2022
DOI: 10.1097/hs9.0000000000000729
Links
Tools
Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
Journal article published in 2022 by
Nadine Kutsch,
Christian Pallasch 
,
Thomas Decker,
Holger Hebart,
Kai Uwe Chow,
Ullrich Graeven,
Jens Kisro,
Alexander Kroeber,
Eugen Tausch,
Kirsten Fischer,
Anna-Maria Fink,
Clemens-Martin Wendtner,
Matthias Ritgen,
Stephan Stilgenbauer,
Danjie Zhang
and other authors.
,
Thomas Decker,
Holger Hebart,
Kai Uwe Chow,
Ullrich Graeven,
Jens Kisro,
Alexander Kroeber,
Eugen Tausch,
Kirsten Fischer,
Anna-Maria Fink,
Clemens-Martin Wendtner,
Matthias Ritgen,
Stephan Stilgenbauer,
Danjie Zhang
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 